DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
People / Ansbert Gadicke
Ansbert Gadicke
Roles
1 current, 0 past
Investments attributed to this person
0
No investment attributed yet. Attribution needs a source naming this person on the deal: a quote, a board seat, a portfolio page credit.
Board seats and vehicles
0 boards, 9 vehicles
- Oncology Investors of Texas Costim, LLC Director Sep 5, 2013
- MPM Bioventures 2018 (b), L.P. Executive Officer/Promoter Feb 23, 2018
- MPM Bioventures 2018, L.P. Executive Officer/Promoter Feb 22, 2018
- MPM Oncology Innovations Fund L.P. Executive Officer/Promoter Jun 29, 2018
- MPM Bioventures V, L.P. Promoter Feb 12, 2010
- MPM Bioventures 2014, L.P. Director May 29, 2014
- MPM Bio 2014 Nvs Strategic Fund, L.P. Director May 29, 2014
- Oncology Impact Fund 2, L.P. Executive Officer Nov 22, 2021
- MPM Bioventures 2022, L.P. Executive Officer May 5, 2022
Timeline
0
No dated event.